en
Scientific article
English

Validation of color Doppler EUS for azygos blood flow measurement in patients with cirrhosis: application to the acute hemodynamic effects of somatostatin, octreotide, or placebo

Published inGastrointestinal endoscopy, vol. 54, no. 1, p. 24-30
Publication date2001
Abstract

Color Doppler EUS (CD-EUS) allows minimally invasive measurement of azygos blood flow (AzBF) in portal hypertension, but further validation of the method is needed. Because a limited number of patients has been studied, the acute hemodynamic effects of somatostatin and octreotide on AzBF and gastric mucosal perfusion are poorly defined in portal hypertension.

Keywords
  • Aged
  • Azygos Vein/drug effects/ultrasonography
  • Blood Flow Velocity/drug effects
  • Double-Blind Method
  • Endosonography
  • Female
  • Humans
  • Hypertension, Portal/drug therapy/ultrasonography
  • Injections, Intravenous
  • Liver Cirrhosis/drug therapy/ultrasonography
  • Male
  • Middle Aged
  • Octreotide/administration & dosage/adverse effects
  • Reproducibility of Results
  • Somatostatin/administration & dosage/adverse effects
  • Thermodilution
  • Treatment Outcome
  • Ultrasonography, Doppler, Color/drug effects
Citation (ISO format)
NISHIDA VUICHARD, Hanae et al. Validation of color Doppler EUS for azygos blood flow measurement in patients with cirrhosis: application to the acute hemodynamic effects of somatostatin, octreotide, or placebo. In: Gastrointestinal endoscopy, 2001, vol. 54, n° 1, p. 24–30. doi: 10.1067/mge.2001.115336
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0016-5107
541views
0downloads

Technical informations

Creation06/04/2014 3:01:00 PM
First validation06/04/2014 3:01:00 PM
Update time03/14/2023 9:23:41 PM
Status update03/14/2023 9:23:41 PM
Last indexation01/16/2024 11:10:10 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack